Technical Analysis for KPRX - Kiora Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 3.42 5.88% 0.19
KPRX closed up 5.88 percent on Wednesday, November 20, 2024, on 59 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Outside Day Range Expansion 5.88%
Oversold Stochastic Weakness 5.88%
Stochastic Buy Signal Bullish 6.21%
NR7 Range Contraction 6.21%
Narrow Range Bar Range Contraction 6.21%
Inside Day Range Contraction 6.21%
Below Lower BB Weakness 6.21%
Down 3 Days in a Row Weakness 6.21%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 20 hours ago
Rose Above Previous Day's High about 20 hours ago
Rose Above 10 DMA about 20 hours ago
Up 5% about 20 hours ago
Up 1 ATR about 20 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kiora Pharmaceuticals, Inc. Description

EyeGate Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EyeGate's lead product, Ocular Bandage Gel ('OBG'), is based on a modified form of the natural polymer hyaluronic acid. The objective of OBG is to protect the ocular surface in order for the body to re-epithelialize the cornea and improve ocular surface integrity. The product is applied as a clear topical gel, to the damaged ocular surface, and possesses unique properties that help hydrate and protect the ocular surface to allow for wound healing. EyeGate is in clinical evaluation for two different patient populations: (1) patients undergoing photorefractive keratectomy ('PRK') surgery to demonstrate corneal wound repair after refractive surgery; and (2) patients with punctate epitheliopathies ('PE') as a result of dry eye to promote reduction of PEs.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Disease Surgery Disorders Eye Surgery Hyaluronic Acid Lasik Refractive Surgery

Is KPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.982
52 Week Low 3.0
Average Volume 27,631
200-Day Moving Average 4.41
50-Day Moving Average 3.51
20-Day Moving Average 3.56
10-Day Moving Average 3.44
Average True Range 0.22
RSI (14) 47.37
ADX 14.79
+DI 19.65
-DI 18.59
Chandelier Exit (Long, 3 ATRs) 3.49
Chandelier Exit (Short, 3 ATRs) 3.82
Upper Bollinger Bands 3.95
Lower Bollinger Band 3.17
Percent B (%b) 0.32
BandWidth 21.89
MACD Line -0.06
MACD Signal Line -0.02
MACD Histogram -0.0361
Fundamentals Value
Market Cap 26.3 Million
Num Shares 7.69 Million
EPS 0.78
Price-to-Earnings (P/E) Ratio 4.38
Price-to-Sales 535.59
Price-to-Book 33.53
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.75
Resistance 3 (R3) 3.74 3.61 3.69
Resistance 2 (R2) 3.61 3.53 3.62 3.68
Resistance 1 (R1) 3.52 3.48 3.56 3.53 3.66
Pivot Point 3.39 3.39 3.42 3.40 3.39
Support 1 (S1) 3.30 3.31 3.35 3.31 3.18
Support 2 (S2) 3.17 3.26 3.18 3.16
Support 3 (S3) 3.08 3.17 3.15
Support 4 (S4) 3.09